Jeffrey H Samet Selected Research

Substance-Related Disorders (Drug Abuse)

12/2022	Functional Impairment and Cognitive Symptoms Among People with HIV Infection on Chronic Opioid Therapy for Pain: The Impact of Gabapentin and Other Sedating Medications.
7/2022	Prevalence and Correlates of Positive Follow-up Screens in Primary Care for Unhealthy Alcohol and Other Drug Use After a Negative Screen.
1/2022	Stigma and ART initiation among people with HIV and a lifetime history of illicit drug use in Saint-Petersburg, Russia-A prospective cohort analysis.
10/2021	Integrating substance use care into primary care for adolescents and young adults: Lessons learned.
2/2021	Post-traumatic stress disorder and risky opioid use among persons living with HIV and chronic pain.
7/2020	Acceptability and Feasibility of a Mobile Health Application for Video Directly Observed Therapy of Buprenorphine for Opioid Use Disorders in an Office-based Setting.
1/2020	Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.
4/2019	HIV Physicians and Chronic Opioid Therapy: It's Time to Raise the Bar.
11/2018	Closing the gaps in opioid use disorder research, policy and practice: conference proceedings.
6/2018	Alcohol Consumption and Bone Mineral Density in People with HIV and Substance Use Disorder: A Prospective Cohort Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey H Samet Research Topics

Disease

46	Substance-Related Disorders (Drug Abuse) 12/2022 - 04/2002
32	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 01/2006
22	Alcoholism (Alcohol Abuse) 07/2022 - 04/2004
22	Alcohol-Related Disorders 04/2014 - 05/2003
17	Pain (Aches) 12/2022 - 05/2007
15	Chronic Pain 01/2022 - 11/2010
13	HIV Infections (HIV Infection) 12/2022 - 08/2006
11	Inflammation (Inflammations) 01/2022 - 08/2013
11	Hepatitis C 08/2021 - 03/2013
10	Disease Progression 01/2020 - 05/2003
9	Infections 01/2022 - 05/2007
8	Marijuana Use 10/2019 - 11/2010
6	Chronic Disease (Chronic Diseases) 01/2021 - 09/2009
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 08/2013
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 01/2011
4	Opiate Overdose 01/2022 - 01/2020
4	Coinfection 08/2021 - 03/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 03/2020 - 09/2009
3	Endocarditis 12/2021 - 10/2020
3	Fibrosis (Cirrhosis) 01/2019 - 08/2013
3	Viremia 01/2018 - 08/2013
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2015 - 05/2003
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 02/2021 - 04/2008
2	Mental Disorders (Mental Disorder) 01/2019 - 12/2012
2	Prescription Drug Misuse 05/2016 - 08/2014
2	Hypertension (High Blood Pressure) 12/2015 - 05/2002
2	Liver Diseases (Liver Disease) 05/2007 - 09/2006
1	Sleepiness 12/2022
1	Neurobehavioral Manifestations 12/2022
1	Dizziness (Lightheadedness) 12/2022
1	Reinfection 01/2021
1	Cancer Pain 01/2020
1	Pneumonia (Pneumonitis) 01/2019
1	Drug Overdose 11/2018
1	Erectile Dysfunction 02/2010
1	Osteomalacia 09/2009

Drug/Important Bio-Agent (IBA)

48	Pharmaceutical PreparationsIBA 07/2022 - 04/2002
41	Opioid Analgesics (Opioids)IBA 12/2022 - 01/2006
18	Buprenorphine (Subutex)FDA LinkGeneric 01/2022 - 01/2006
14	Methadone (Dolophine)FDA LinkGeneric 01/2022 - 05/2003
14	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2003
12	Cocaine (Cocaine HCl)IBA 01/2022 - 01/2007
12	Biomarkers (Surrogate Marker)IBA 10/2020 - 05/2007
9	Heroin (Diamorphine)IBA 01/2017 - 01/2007
6	phosphatidylethanolIBA 07/2022 - 12/2015
6	Interleukin-6 (Interleukin 6)IBA 01/2020 - 08/2013
6	Illicit Drugs (Recreational Drugs)IBA 01/2019 - 10/2013
5	ZincIBA 01/2021 - 01/2018
5	Ethanol (Ethyl Alcohol)IBA 03/2016 - 12/2006
4	BenzodiazepinesIBA 02/2021 - 11/2012
4	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 09/2012 - 12/2006
3	Naltrexone (ReVia)FDA LinkGeneric 01/2020 - 01/2017
3	Lipopolysaccharide ReceptorsIBA 01/2019 - 12/2015
3	fibrin fragment D (D-dimer)IBA 01/2019 - 12/2015
3	Prescription DrugsIBA 05/2016 - 11/2010
3	Biological ProductsIBA 12/2015 - 02/2009
2	Morphine (MS Contin)FDA LinkGeneric 02/2021 - 10/2019
2	Naloxone (Narcan)FDA LinkGeneric 01/2021 - 03/2011
2	EnzymesIBA 01/2018 - 09/2013
2	Transaminases (Aminotransferases)IBA 10/2017 - 03/2013
2	CytokinesIBA 04/2014 - 08/2013
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2013 - 03/2013
2	Analgesics (Analgesic Drugs)IBA 01/2012 - 11/2010
2	Vitamin D FDA LinkGeneric 09/2009 - 12/2006
1	Gabapentin (Neurontin)FDA LinkGeneric 12/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	P 11 (P-11)IBA 10/2021
1	Nicotine FDA Link 10/2021
1	Narcotic Antagonists (Opioid Antagonists)IBA 03/2021
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021
1	Medical MarijuanaIBA 10/2019
1	A-factor (Streptomyces)IBA 01/2019
1	N-nitrosoiminodiacetic acidIBA 11/2018
1	SmokeIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	CannabinoidsIBA 01/2017
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2017
1	Opiate AlkaloidsIBA 09/2016
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2016
1	Aligeron (AS 2)IBA 12/2015
1	N 563IBA 01/2015
1	C-Reactive ProteinIBA 08/2013
1	InterleukinsIBA 08/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2013
1	Interleukin-10 (Interleukin 10)IBA 08/2013
1	Alanine Transaminase (SGPT)IBA 03/2013
1	Indicators and Reagents (Reagents)IBA 12/2012
1	carbohydrate-deficient transferrinIBA 11/2011
1	TabletsIBA 03/2011
1	Narcotics (Narcotic Analgesics)IBA 01/2011

Therapy/Procedure

30	Therapeutics 12/2022 - 03/2004
6	Art Therapy 12/2017 - 01/2005
4	Highly Active Antiretroviral Therapy (HAART) 09/2007 - 05/2003
3	Pain Management 01/2021 - 02/2011
2	Retention in Care 10/2021 - 11/2018
2	Drug Therapy (Chemotherapy) 01/2020 - 12/2015
1	Continuity of Patient Care 08/2021
1	Aftercare (After-Treatment) 01/2021
1	Ambulatory Care (Outpatient Care) 03/2020
1	Injections 01/2020